Evidence map›Paper›PMID 29121921›Full record

ArticleCardiovascular diabetology2017

Transcatheter aortic valve implantation and surgical aortic valve replacement among hospitalized patients with and without type 2 diabetes mellitus in Spain (2014-2015).

Manuel Mendez-Bailon, Noel Lorenzo-Villalba, Nuria Muñoz-Rivas, Jose Maria de Miguel-Yanes, Javier De Miguel-Diez, Josep Comín-Colet, Valentin Hernandez-Barrera, Rodrigo Jimenez-Garcia, Ana Lopez-de-Andres

Open access · goldAbstract readComparative Study
In one paragraph

Article in Cardiovascular diabetology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Towards Personalized Therapy of Aortic Stenosis.Journal of personalized medicine · 2021
    Review
  14. Diabetes Mellitus and Its Implications in Aortic Stenosis Patients.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Trends in Utilization and In-hospital Outcomes of Cardiac Surgery.Brazilian journal of cardiovascular surgery · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Manuel Mendez-BailonInternal Medicine Department, Instituto de Investigación Cardiovascular, Hospital Clínico San Carlos, Complutense University, Madrid, Spain.
Noel Lorenzo-VillalbaService de Médicine Interne et Cancerlogie, Centre Hospitalier Saint Cyr, Lyon, France.
Nuria Muñoz-RivasInternal Medicine Department, Hospital Universitario Infanta Leonor, Madrid, Spain.
Jose Maria de Miguel-YanesInternal Medicine Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
Javier De Miguel-DiezPneumology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
Josep Comín-ColetDepartment of Cardiology, Hospital Universitario de Bellvitge, Barcelona, Spain.
Valentin Hernandez-BarreraPreventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Rey Juan Carlos University, Avda. de Atenas s/n, 28922, Alcorcón, Madrid, Spain.
Rodrigo Jimenez-GarciaPreventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Rey Juan Carlos University, Avda. de Atenas s/n, 28922, Alcorcón, Madrid, Spain. rodrigo.jimenez@urjc.es.
Ana Lopez-de-AndresPreventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Rey Juan Carlos University, Avda. de Atenas s/n, 28922, Alcorcón, Madrid, Spain.
Universidad Rey Juan Carlos · ESHospital General Universitario Gregorio Marañón · ESBellvitge University Hospital · ESHospital Clínico San Carlos · ESHospital Universitario Infanta Leonor · ES

Funding

FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") PI16/00564Grupo de Excelencia Investigadora URJC-Banco Santander: Investigación traslacional en el proceso de salud - enfermedad (ITPSE). 30VCPIGI03
6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) is strongly related to the in-hospital and short-term prognosis in patients with cardiovascular diseases needing surgical or invasive interventions. How T2DM might influence the treatment of aortic stenosis (AS) has not been completely elucidated for surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI). The aims of this study were: (1) to describe the use of aortic valve replacement procedures (TAVI and SAVR) among hospitalized patients with and without T2DM; and (2) to identify factors associated with in hospital mortality (IHM) among patients undergoing these procedures.

methodsWe analyzed data from the Spanish National Hospital Discharge Database between January 1, 2014 and December 31, 2015 for patients aged ≥ 40 years. We selected patients whose medical procedures included TAVI (ICD-9-CM codes 35.05, 35.06) and SAVR (ICD-9-CM codes 35.21, 35.22). We stratified each cohort by diabetes status: T2DM (ICD-9-CM codes 250.x0, 250.x2) and no diabetes. We retrieved data about specific comorbidities, risk factors, procedures, and specific in-hospital postoperative complications. Hospital outcome variables included IHM, and length of hospital stay (LOHS).

resultsWe identified a total of 2141 and 16,013 patients who underwent TAVI (n = 715; 33.39% with T2DM) and SAVR (n = 4057; 25.33% with T2DM). In patients who underwent TAVI we found no differences in IHM (3.64% in T2DM vs. 5.12% in non-T2DM, p = 0.603). In the cohort of SAVR, mean LOHS was significantly lower in patients with T2DM than in non-diabetic patients (13.77 vs. 17.27 days). IHM was lower in patients with T2DM (4.36% vs. 6.31%, p < 0.01). After multivariable adjustment for both procedures, patients with T2DM had significantly lower IHM than patients without diabetes (adjusted OR 0.60; IC 95% 0.37-0.99 for TAVI and adjusted OR 0.80; IC 95% 0.66-0-96 for SAVR).

conclusionsT2DM diabetic patients with AS undergoing a valvular replacement procedure through SAVR or TAVI did not have a worse prognosis compared to non-diabetic patients during hospitalization, showing lower IHM after multivariable adjustment. However, given the limitations of administrative data more prospective studies and clinical trials aimed at evaluating the influence of these procedures in diabetic patients with AS are needed.

Indexed as

AdultAgedAged, 80 and overAortic Valve StenosisDatabases, FactualDiabetes Mellitus, Type 2FemaleHeart Valve Prosthesis ImplantationHospitalizationHumansMaleMiddle AgedSpainTranscatheter Aortic Valve ReplacementHospitalMortalitySurgical aortic valve replacementTranscatheter aortic valve implantationType 2 diabetes

Identifiers

PMID29121921
PMCPMC5679322
OpenAlexW2767772816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.